WASHINGTON, D.C. -- Oct. 22, 2018 -- Dr. Daniel D. Von Hoff, Distinguished Professor and Physician-In-Chief of the Translational Genomics...
INDIANAPOLIS - A systematic review and meta-analysis from the Regenstrief Institute and Indiana University School of Medicine has found that,...
SAN ANTONIO, October 23, 2018 -- A highly sensitive blood test that detects minute traces of cancer-specific DNA has been...
CHAPEL HILL - A new blood test developed by University of North Carolina Lineberger Comprehensive Cancer Center researchers shows promise...
(Vienna, October 23, 2018) Oesophageal microbiota may help to improve the diagnosis and management of oesophageal cancer, according to the...
SAN ANTONIO, October 22, 2018 -- Combinations of radiation and chemotherapy drugs have been shown to cure HPV-related head and...
SAN ANTONIO, October 22, 2018 -- The first report of a large international clinical trial shows that, for men who...
SAN ANTONIO, October 22, 2018 -- While popular beliefs and population data suggest that African-American men are at higher risk...
SAN ANTONIO, October 22, 2018 -- Stereotactic body radiation therapy (SBRT) is a safe and effective treatment for men with...
SAN ANTONIO, October 22, 2018 -- Treatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective...
Credit: MD Anderson Cancer Center Researchers at The University of Texas MD Anderson Cancer Center have discovered that a form...
Credit: UPMC PITTSBURGH, Oct 20, 2018 - Patients with an aggressive form of advanced breast cancer can benefit from immunotherapy...
Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - There is growing evidence that drugs approved...
Combining a targeted drug with hormone therapy substantially extends survival for women with advanced breast cancer, a major clinical trial...
Credit: © European Society for Medical Oncology Munich, Germany, 20 October 2018 - Treatment with the cyclin dependent kinase (CDK)...
Credit: © European Society for Medical Oncology Munich, Germany, 20 October 2018 - Immunotherapy improves survival in some patients with...
Munich, Germany, 21 October 2018 - Neoadjuvant erlotinib benefits selected epidermal growth factor receptor (EGFR)-mutated patients who undergo complete resection...
Oncology trial RTOG 0232 comparing a combined treatment of external beam therapy and brachytherapy (EBT+B) to transperineal interstitial permanent brachytherapy...
Data from a validation study of NRG-RTOG 0521 suggests that, while there is no association between an elevated level of...
A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.